Bullous pemphigoid is an autoimmune disease that causes blistering of the skin and is most commonly seen in older patients. It is associated with high morbidity and mortality, and the incidence is increasing. Few studies of effective and safe treatments have been done, but a Cochrane review recommends first-line treatment with topical corticosteroids. Professor Fenella Wojnarowska, a leading expert on this condition and coauthor of the Cochrane review, recently gave a presentation about this disease at the 4th Medical Dermatology Conference, London.